Article Information
History
- May 24, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gabriel Balmus1,2,‡,
- Domenic Pilger1,‡,
- Julia Coates1,
- Mukerrem Demir1,
- Matylda Sczaniecka-Clift1,
- Ana Barros2,
- Michael Woods2,
- Beiyuan Fu2,
- Fengtang Yang2,
- Elisabeth Chen2,
- Matthias Ostermaier3,
- Tatjana Stankovic4,
- Hannes Ponstingl2,
- Mareike Herzog1,2,
- Kosuke Yusa2,
- Francisco Munoz Martinez1,
- Stephen T. Durant5,
- Yaron Galanty1,
- Petra Beli3,
- David J. Adams2,
- Allan Bradley2,
- Emmanouil Metzakopian2,
- Josep V. Forment1,5,6,‡ and
- Stephen P. Jackson1,6
- 1The Wellcome Trust and Cancer Research UK Gurdon Institute and Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK
- 2Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK
- 3Institute of Molecular Biology (IMB), 55128 Mainz, Germany
- 4Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
- 5DNA Damage Response Biology, Bioscience Oncology IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG, UK
- ↵6Correspondence should be addressed. Correspondence to s.jackson{at}gurdon.cam.ac.uk (Lead contact); josep.forment{at}astrazeneca.com
↵‡ These authors contributed equally to this work.